Cite
Shailubhai K, Palejwala V, Arjunan KP, et al. Plecanatide and dolcanatide, novel guanylate cyclase-C agonists, ameliorate gastrointestinal inflammation in experimental models of murine colitis. World J Gastrointest Pharmacol Ther. 2015;6(4):213-22doi: 10.4292/wjgpt.v6.i4.213.
Shailubhai, K., Palejwala, V., Arjunan, K. P., Saykhedkar, S., Nefsky, B., Foss, J. A., Comiskey, S., Jacob, G. S., & Plevy, S. E. (2015). Plecanatide and dolcanatide, novel guanylate cyclase-C agonists, ameliorate gastrointestinal inflammation in experimental models of murine colitis. World journal of gastrointestinal pharmacology and therapeutics, 6(4), 213-22. https://doi.org/10.4292/wjgpt.v6.i4.213
Shailubhai, Kunwar, et al. "Plecanatide and dolcanatide, novel guanylate cyclase-C agonists, ameliorate gastrointestinal inflammation in experimental models of murine colitis." World journal of gastrointestinal pharmacology and therapeutics vol. 6,4 (2015): 213-22. doi: https://doi.org/10.4292/wjgpt.v6.i4.213
Shailubhai K, Palejwala V, Arjunan KP, Saykhedkar S, Nefsky B, Foss JA, Comiskey S, Jacob GS, Plevy SE. Plecanatide and dolcanatide, novel guanylate cyclase-C agonists, ameliorate gastrointestinal inflammation in experimental models of murine colitis. World J Gastrointest Pharmacol Ther. 2015 Nov 06;6(4):213-22. doi: 10.4292/wjgpt.v6.i4.213. PMID: 26558155; PMCID: PMC4635161.
Copy
Download .nbib